iShares Core MSCI EM IMI UCITS ETF
iShares Core MSCI EM IMI UCITS ETF (EMIM.L) Stock Competitors & Peer Comparison
See (EMIM.L) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMIM.L | £2,965.00 | -1.40% | 2T | N/A | N/A | N/A |
| IUSA.L | £4,688.50 | -2.53% | 1.4T | N/A | N/A | +101.78% |
| SSAC.L | £7,361.00 | -2.11% | 1.1T | N/A | N/A | N/A |
| EQGB.L | £43,425.00 | -2.72% | 1.1T | N/A | N/A | N/A |
| SMEA.L | £7,314.00 | -1.68% | 943.1B | N/A | N/A | N/A |
| IITU.L | £2,827.00 | -2.92% | 919B | N/A | N/A | N/A |
| XESC.L | £7,835.00 | -2.11% | 817.1B | N/A | N/A | N/A |
| XESX.L | £4,756.00 | -2.12% | 817.1B | N/A | N/A | +2.75% |
| UB0D.L | £2,222.25 | -1.74% | 781.9B | N/A | N/A | +1.71% |
| MEUD.L | £22,245.00 | -1.63% | 769.1B | N/A | N/A | N/A |
Stock Comparison
EMIM.L vs IUSA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IUSA.L has a market cap of 1.4T. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IUSA.L trades at £4,688.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IUSA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IUSA.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to IUSA.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IUSA.L's competition here
EMIM.L vs SSAC.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SSAC.L has a market cap of 1.1T. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SSAC.L trades at £7,361.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SSAC.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SSAC.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to SSAC.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SSAC.L's competition here
EMIM.L vs EQGB.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, EQGB.L has a market cap of 1.1T. Regarding current trading prices, EMIM.L is priced at £2,965.00, while EQGB.L trades at £43,425.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas EQGB.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to EQGB.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to EQGB.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check EQGB.L's competition here
EMIM.L vs SMEA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SMEA.L has a market cap of 943.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SMEA.L trades at £7,314.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SMEA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SMEA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to SMEA.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check SMEA.L's competition here
EMIM.L vs IITU.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IITU.L has a market cap of 919B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IITU.L trades at £2,827.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IITU.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IITU.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IITU.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IITU.L's competition here
EMIM.L vs XESC.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XESC.L has a market cap of 817.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XESC.L trades at £7,835.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XESC.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XESC.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XESC.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XESC.L's competition here
EMIM.L vs XESX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XESX.L has a market cap of 817.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XESX.L trades at £4,756.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XESX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XESX.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to XESX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XESX.L's competition here
EMIM.L vs UB0D.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UB0D.L has a market cap of 781.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UB0D.L trades at £2,222.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UB0D.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UB0D.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to UB0D.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check UB0D.L's competition here
EMIM.L vs MEUD.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, MEUD.L has a market cap of 769.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while MEUD.L trades at £22,245.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas MEUD.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to MEUD.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to MEUD.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check MEUD.L's competition here
EMIM.L vs CNAL.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CNAL.L has a market cap of 679.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CNAL.L trades at £12,033.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CNAL.L's P/E ratio is -11.25. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CNAL.L's ROE of +0.32%. Regarding short-term risk, EMIM.L is more volatile compared to CNAL.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check CNAL.L's competition here
EMIM.L vs IWRD.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWRD.L has a market cap of 594.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWRD.L trades at £6,451.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWRD.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWRD.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IWRD.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWRD.L's competition here
EMIM.L vs XMMS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XMMS.L has a market cap of 547.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XMMS.L trades at £4,945.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XMMS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XMMS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XMMS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XMMS.L's competition here
EMIM.L vs XDAX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XDAX.L has a market cap of 534.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XDAX.L trades at £19,166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XDAX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XDAX.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to XDAX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XDAX.L's competition here
EMIM.L vs PHGP.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, PHGP.L has a market cap of 514.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while PHGP.L trades at £23,543.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas PHGP.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to PHGP.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to PHGP.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check PHGP.L's competition here
EMIM.L vs MXWS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, MXWS.L has a market cap of 511.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while MXWS.L trades at £9,527.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas MXWS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to MXWS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to MXWS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check MXWS.L's competition here
EMIM.L vs XMUS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XMUS.L has a market cap of 509.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XMUS.L trades at £14,023.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XMUS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XMUS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XMUS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XMUS.L's competition here
EMIM.L vs GLDA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, GLDA.L has a market cap of 501.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while GLDA.L trades at £10,029.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas GLDA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to GLDA.L's ROE of N/A. Regarding short-term risk, EMIM.L is more volatile compared to GLDA.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check GLDA.L's competition here
EMIM.L vs XMEU.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XMEU.L has a market cap of 479.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XMEU.L trades at £8,361.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XMEU.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XMEU.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to XMEU.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check XMEU.L's competition here
EMIM.L vs UC44.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UC44.L has a market cap of 462.2B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UC44.L trades at £12,996.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UC44.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UC44.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to UC44.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check UC44.L's competition here
EMIM.L vs CS51.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CS51.L has a market cap of 441.2B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CS51.L trades at £17,116.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CS51.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CS51.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CS51.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CS51.L's competition here
EMIM.L vs IEEM.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IEEM.L has a market cap of 398.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IEEM.L trades at £3,616.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IEEM.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IEEM.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to IEEM.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check IEEM.L's competition here
EMIM.L vs UB32.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UB32.L has a market cap of 393.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UB32.L trades at £9,133.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UB32.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UB32.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to UB32.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check UB32.L's competition here
EMIM.L vs EUE.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, EUE.L has a market cap of 378.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while EUE.L trades at £4,638.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas EUE.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to EUE.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to EUE.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check EUE.L's competition here
EMIM.L vs SEMA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SEMA.L has a market cap of 351.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SEMA.L trades at £3,414.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SEMA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SEMA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to SEMA.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check SEMA.L's competition here
EMIM.L vs CACX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CACX.L has a market cap of 334.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CACX.L trades at £6,634.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CACX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CACX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CACX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CACX.L's competition here
EMIM.L vs XSX6.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XSX6.L has a market cap of 321.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XSX6.L trades at £11,788.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XSX6.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XSX6.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to XSX6.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check XSX6.L's competition here
EMIM.L vs IWFQ.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWFQ.L has a market cap of 315.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWFQ.L trades at £5,447.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWFQ.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWFQ.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IWFQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWFQ.L's competition here
EMIM.L vs GBSS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, GBSS.L has a market cap of 305.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while GBSS.L trades at £23,182.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas GBSS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to GBSS.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to GBSS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check GBSS.L's competition here
EMIM.L vs IWFV.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWFV.L has a market cap of 282.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWFV.L trades at £3,726.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWFV.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWFV.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IWFV.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWFV.L's competition here
EMIM.L vs SGBX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SGBX.L has a market cap of 279.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SGBX.L trades at £24,203.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SGBX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SGBX.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to SGBX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SGBX.L's competition here
EMIM.L vs CEA1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CEA1.L has a market cap of 263.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CEA1.L trades at £15,588.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CEA1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CEA1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CEA1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CEA1.L's competition here
EMIM.L vs RBTX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, RBTX.L has a market cap of 250.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while RBTX.L trades at £1,124.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas RBTX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to RBTX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to RBTX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check RBTX.L's competition here
EMIM.L vs ISPY.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, ISPY.L has a market cap of 245B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while ISPY.L trades at £2,290.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas ISPY.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to ISPY.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to ISPY.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check ISPY.L's competition here
EMIM.L vs CPJ1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CPJ1.L has a market cap of 243.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CPJ1.L trades at £15,687.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CPJ1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CPJ1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CPJ1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CPJ1.L's competition here
EMIM.L vs SUES.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SUES.L has a market cap of 241.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SUES.L trades at £630.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SUES.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SUES.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to SUES.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check SUES.L's competition here
EMIM.L vs JRDE.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, JRDE.L has a market cap of 237.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while JRDE.L trades at £3,607.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas JRDE.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to JRDE.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to JRDE.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check JRDE.L's competition here
EMIM.L vs JERE.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, JERE.L has a market cap of 235.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while JERE.L trades at £3,890.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas JERE.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to JERE.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to JERE.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check JERE.L's competition here
EMIM.L vs IWFM.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWFM.L has a market cap of 231.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWFM.L trades at £6,764.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWFM.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWFM.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IWFM.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWFM.L's competition here
EMIM.L vs PHSP.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, PHSP.L has a market cap of 217.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while PHSP.L trades at £2,547.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas PHSP.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to PHSP.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to PHSP.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check PHSP.L's competition here
EMIM.L vs HMEF.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, HMEF.L has a market cap of 211B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while HMEF.L trades at £917.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas HMEF.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to HMEF.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to HMEF.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check HMEF.L's competition here
EMIM.L vs IUQF.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IUQF.L has a market cap of 199.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IUQF.L trades at £1,149.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IUQF.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IUQF.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IUQF.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IUQF.L's competition here
EMIM.L vs SPGP.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SPGP.L has a market cap of 198.2B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SPGP.L trades at £1,816.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SPGP.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SPGP.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to SPGP.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SPGP.L's competition here
EMIM.L vs XXSC.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XXSC.L has a market cap of 195.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XXSC.L trades at £5,633.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XXSC.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XXSC.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XXSC.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XXSC.L's competition here
EMIM.L vs XDEV.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XDEV.L has a market cap of 187.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XDEV.L trades at £3,836.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XDEV.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XDEV.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XDEV.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XDEV.L's competition here
EMIM.L vs UIFS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UIFS.L has a market cap of 186.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UIFS.L trades at £1,130.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UIFS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UIFS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to UIFS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check UIFS.L's competition here
EMIM.L vs SOYU.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SOYU.L has a market cap of 172.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SOYU.L trades at £296.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SOYU.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SOYU.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to SOYU.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check SOYU.L's competition here
EMIM.L vs CEUR.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CEUR.L has a market cap of 169.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CEUR.L trades at £30,900.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CEUR.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CEUR.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to CEUR.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check CEUR.L's competition here
EMIM.L vs XDEQ.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XDEQ.L has a market cap of 161.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XDEQ.L trades at £5,550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XDEQ.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XDEQ.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XDEQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XDEQ.L's competition here
EMIM.L vs CU1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CU1.L has a market cap of 157.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CU1.L trades at £48,490.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CU1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CU1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CU1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CU1.L's competition here
EMIM.L vs PRIR.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, PRIR.L has a market cap of 154.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while PRIR.L trades at £1,510.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas PRIR.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to PRIR.L's ROE of N/A. Regarding short-term risk, EMIM.L is more volatile compared to PRIR.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check PRIR.L's competition here
EMIM.L vs IEFV.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IEFV.L has a market cap of 152.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IEFV.L trades at £888.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IEFV.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IEFV.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IEFV.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IEFV.L's competition here
EMIM.L vs GBSP.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, GBSP.L has a market cap of 148.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while GBSP.L trades at £1,723.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas GBSP.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to GBSP.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to GBSP.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check GBSP.L's competition here
EMIM.L vs WATL.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, WATL.L has a market cap of 143.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while WATL.L trades at £6,000.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas WATL.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to WATL.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to WATL.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check WATL.L's competition here
EMIM.L vs IPRP.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IPRP.L has a market cap of 143.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IPRP.L trades at £2,648.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IPRP.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IPRP.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IPRP.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IPRP.L's competition here
EMIM.L vs ISP6.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, ISP6.L has a market cap of 142.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while ISP6.L trades at £6,588.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas ISP6.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to ISP6.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to ISP6.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check ISP6.L's competition here
EMIM.L vs UC79.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UC79.L has a market cap of 136.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UC79.L trades at £1,167.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UC79.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UC79.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to UC79.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check UC79.L's competition here
EMIM.L vs CUS1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CUS1.L has a market cap of 135.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CUS1.L trades at £39,325.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CUS1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CUS1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CUS1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CUS1.L's competition here
EMIM.L vs CG1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CG1.L has a market cap of 134.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CG1.L trades at £36,297.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CG1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CG1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CG1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CG1.L's competition here
EMIM.L vs GILS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, GILS.L has a market cap of 133B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while GILS.L trades at £10,233.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas GILS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to GILS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to GILS.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check GILS.L's competition here
EMIM.L vs XCX6.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XCX6.L has a market cap of 133B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XCX6.L trades at £1,398.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XCX6.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XCX6.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to XCX6.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check XCX6.L's competition here
EMIM.L vs INFL.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, INFL.L has a market cap of 126.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while INFL.L trades at £10,136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas INFL.L's P/E ratio is 4.21. In terms of profitability, EMIM.L's ROE is +0.00%, compared to INFL.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to INFL.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check INFL.L's competition here
EMIM.L vs CB5.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CB5.L has a market cap of 126.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CB5.L trades at £4,140.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CB5.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CB5.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CB5.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CB5.L's competition here
EMIM.L vs IJPN.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IJPN.L has a market cap of 124.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IJPN.L trades at £1,413.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IJPN.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IJPN.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IJPN.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IJPN.L's competition here
EMIM.L vs XDEM.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XDEM.L has a market cap of 124.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XDEM.L trades at £5,694.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XDEM.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XDEM.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XDEM.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XDEM.L's competition here
EMIM.L vs CSPX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CSPX.L has a market cap of 123.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CSPX.L trades at £665.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CSPX.L's P/E ratio is 26.92. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CSPX.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to CSPX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CSPX.L's competition here
EMIM.L vs GSPX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, GSPX.L has a market cap of 123.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while GSPX.L trades at £10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas GSPX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to GSPX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to GSPX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check GSPX.L's competition here
EMIM.L vs XZEU.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XZEU.L has a market cap of 123.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XZEU.L trades at £2,760.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XZEU.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XZEU.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to XZEU.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check XZEU.L's competition here
EMIM.L vs SP5G.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SP5G.L has a market cap of 122.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SP5G.L trades at £211.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SP5G.L's P/E ratio is 65.84. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SP5G.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to SP5G.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SP5G.L's competition here
EMIM.L vs IGSG.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IGSG.L has a market cap of 122.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IGSG.L trades at £6,092.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IGSG.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IGSG.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IGSG.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IGSG.L's competition here
EMIM.L vs H50E.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, H50E.L has a market cap of 117.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while H50E.L trades at £4,829.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas H50E.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to H50E.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to H50E.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check H50E.L's competition here
EMIM.L vs 0GWB.IL Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, 0GWB.IL has a market cap of 117.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while 0GWB.IL trades at £469.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas 0GWB.IL's P/E ratio is 15.47. In terms of profitability, EMIM.L's ROE is +0.00%, compared to 0GWB.IL's ROE of +0.06%. Regarding short-term risk, EMIM.L is less volatile compared to 0GWB.IL. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check 0GWB.IL's competition here
EMIM.L vs XRSG.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XRSG.L has a market cap of 113.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XRSG.L trades at £23,925.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XRSG.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XRSG.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to XRSG.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XRSG.L's competition here
EMIM.L vs IWDA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWDA.L has a market cap of 112.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWDA.L trades at £117.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWDA.L's P/E ratio is 23.62. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWDA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IWDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWDA.L's competition here
EMIM.L vs IWDG.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IWDG.L has a market cap of 112.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IWDG.L trades at £1,016.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IWDG.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IWDG.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to IWDG.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IWDG.L's competition here
EMIM.L vs JRDM.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, JRDM.L has a market cap of 112.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while JRDM.L trades at £2,433.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas JRDM.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to JRDM.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to JRDM.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check JRDM.L's competition here
EMIM.L vs PRIC.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, PRIC.L has a market cap of 111.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while PRIC.L trades at £1,666.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas PRIC.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to PRIC.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to PRIC.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check PRIC.L's competition here
EMIM.L vs IEUX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IEUX.L has a market cap of 110B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IEUX.L trades at £3,964.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IEUX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IEUX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IEUX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IEUX.L's competition here
EMIM.L vs DAXX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, DAXX.L has a market cap of 105.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while DAXX.L trades at £18,685.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas DAXX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to DAXX.L's ROE of N/A. Regarding short-term risk, EMIM.L is more volatile compared to DAXX.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check DAXX.L's competition here
EMIM.L vs EQSG.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, EQSG.L has a market cap of 105.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while EQSG.L trades at £5,370.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas EQSG.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to EQSG.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to EQSG.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check EQSG.L's competition here
EMIM.L vs WQDS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, WQDS.L has a market cap of 103B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while WQDS.L trades at £561.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas WQDS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to WQDS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to WQDS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check WQDS.L's competition here
EMIM.L vs CSCA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CSCA.L has a market cap of 102.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CSCA.L trades at £17,732.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CSCA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CSCA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CSCA.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CSCA.L's competition here
EMIM.L vs XLKQ.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XLKQ.L has a market cap of 102.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XLKQ.L trades at £58,075.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XLKQ.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XLKQ.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XLKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XLKQ.L's competition here
EMIM.L vs COMM.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, COMM.L has a market cap of 101.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while COMM.L trades at £543.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas COMM.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to COMM.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to COMM.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check COMM.L's competition here
EMIM.L vs IUKD.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IUKD.L has a market cap of 97.2B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IUKD.L trades at £844.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IUKD.L's P/E ratio is 14.81. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IUKD.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to IUKD.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check IUKD.L's competition here
EMIM.L vs MTIX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, MTIX.L has a market cap of 96.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while MTIX.L trades at £14,524.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas MTIX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to MTIX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to MTIX.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check MTIX.L's competition here
EMIM.L vs PRIJ.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, PRIJ.L has a market cap of 95.9B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while PRIJ.L trades at £2,474.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas PRIJ.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to PRIJ.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to PRIJ.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check PRIJ.L's competition here
EMIM.L vs UB45.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, UB45.L has a market cap of 94.4B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while UB45.L trades at £6,194.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas UB45.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to UB45.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to UB45.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check UB45.L's competition here
EMIM.L vs INAA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, INAA.L has a market cap of 93.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while INAA.L trades at £8,734.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas INAA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to INAA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to INAA.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check INAA.L's competition here
EMIM.L vs IMV.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IMV.L has a market cap of 93.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IMV.L trades at £5,714.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IMV.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IMV.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to IMV.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check IMV.L's competition here
EMIM.L vs CSP1.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CSP1.L has a market cap of 93.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CSP1.L trades at £50,174.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CSP1.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CSP1.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to CSP1.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check CSP1.L's competition here
EMIM.L vs IGUS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IGUS.L has a market cap of 93.2B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IGUS.L trades at £14,238.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IGUS.L's P/E ratio is 26.87. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IGUS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IGUS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IGUS.L's competition here
EMIM.L vs RIEG.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, RIEG.L has a market cap of 92.5B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while RIEG.L trades at £1,430.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas RIEG.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to RIEG.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to RIEG.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check RIEG.L's competition here
EMIM.L vs CRPX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, CRPX.L has a market cap of 91.8B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while CRPX.L trades at £13,392.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas CRPX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to CRPX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is more volatile compared to CRPX.L. This indicates potentially higher risk in terms of short-term price fluctuations for EMIM.L.Check CRPX.L's competition here
EMIM.L vs SPEX.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SPEX.L has a market cap of 91.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SPEX.L trades at £4,603.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SPEX.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SPEX.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to SPEX.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SPEX.L's competition here
EMIM.L vs SPES.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SPES.L has a market cap of 91.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SPES.L trades at £4,333.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SPES.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SPES.L's ROE of N/A. Regarding short-term risk, EMIM.L is less volatile compared to SPES.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SPES.L's competition here
EMIM.L vs EQDS.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, EQDS.L has a market cap of 91.3B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while EQDS.L trades at £540.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas EQDS.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to EQDS.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to EQDS.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check EQDS.L's competition here
EMIM.L vs IDVY.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, IDVY.L has a market cap of 88.6B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while IDVY.L trades at £1,896.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas IDVY.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to IDVY.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to IDVY.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check IDVY.L's competition here
EMIM.L vs SWDA.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, SWDA.L has a market cap of 85.1B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while SWDA.L trades at £8,873.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas SWDA.L's P/E ratio is N/A. In terms of profitability, EMIM.L's ROE is +0.00%, compared to SWDA.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to SWDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check SWDA.L's competition here
EMIM.L vs XDN0.L Comparison August 2025
EMIM.L plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMIM.L stands at 2T. In comparison, XDN0.L has a market cap of 84.7B. Regarding current trading prices, EMIM.L is priced at £2,965.00, while XDN0.L trades at £3,980.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMIM.L currently has a P/E ratio of N/A, whereas XDN0.L's P/E ratio is 16.95. In terms of profitability, EMIM.L's ROE is +0.00%, compared to XDN0.L's ROE of +0.00%. Regarding short-term risk, EMIM.L is less volatile compared to XDN0.L. This indicates potentially lower risk in terms of short-term price fluctuations for EMIM.L.Check XDN0.L's competition here